Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	33	46	57	49	45	65	Upgrade
Market Cap Growth	-18.37%	-18.37%	16.67%	9.09%	-31.25%	-27.27%	Upgrade
Enterprise Value	13	19	308	307	294	294	Upgrade
Last Close Price	0.58	0.81	1.40	1.20	1.10	1.60	Upgrade
PS Ratio	0.09	0.13	0.12	0.10	0.11	0.27	Upgrade
PB Ratio	-0.83	-1.16	-0.14	-0.12	-0.12	-0.19	Upgrade
P/FCF Ratio	-	-	59.95	3.38	-	-	Upgrade
P/OCF Ratio	-	-	12.37	2.32	-	-	Upgrade
EV/Sales Ratio	0.04	0.05	0.66	0.62	0.72	1.23	Upgrade
EV/EBITDA Ratio	-	-	27.40	-	-	-	Upgrade
EV/EBIT Ratio	-	-	94.76	-	-	-	Upgrade
EV/FCF Ratio	-1.51	-	325.42	21.31	-	-	Upgrade
Debt / Equity Ratio	-1.01	-1.01	-0.75	-0.77	-0.79	-0.85	Upgrade
Debt / EBITDA Ratio	-	-	19.80	295.86	-	-	Upgrade
Debt / FCF Ratio	-	-	319.91	21.26	-	-	Upgrade
Asset Turnover	1.90	1.90	2.02	2.16	2.10	1.13	Upgrade
Quick Ratio	0.58	0.58	0.26	0.28	0.26	0.24	Upgrade
Current Ratio	0.90	0.90	0.33	0.37	0.32	0.32	Upgrade
Return on Assets (ROA)	-8.05%	-8.05%	0.88%	-2.69%	-7.75%	-21.04%	Upgrade
Earnings Yield	-34.17%	-24.47%	-16.42%	-19.40%	-93.54%	-112.42%	Upgrade
FCF Yield	-26.69%	-	1.67%	29.57%	-65.84%	-29.96%	Upgrade
Buyback Yield / Dilution	-39.34%	-39.34%	-	0.00%	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.